Dupilumab-related eosinophilia in patients with severe asthma: Post-marketing surveillance in Japan.

IF 6.2 2区医学 Q1 ALLERGY

Allergology International Pub Date : 2024-09-10 DOI:10.1016/j.alit.2024.08.003

Makoto Nagata,Ryo Yamaguchi,Makiko Usami,Mami Orimo,Masato Ishida

引用次数: 0

查看原文本刊更多论文

严重哮喘患者中与杜匹单抗相关的嗜酸性粒细胞增多症：日本的上市后监测

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Allergology International ALLERGY-IMMUNOLOGY

CiteScore

12.60

自引率

5.90%

发文量

审稿时长

29 weeks

期刊介绍： Allergology International is the official journal of the Japanese Society of Allergology and publishes original papers dealing with the etiology, diagnosis and treatment of allergic and related diseases. Papers may include the study of methods of controlling allergic reactions, human and animal models of hypersensitivity and other aspects of basic and applied clinical allergy in its broadest sense. The Journal aims to encourage the international exchange of results and encourages authors from all countries to submit papers in the following three categories: Original Articles, Review Articles, and Letters to the Editor.